PUBLIC CONTRACT · 2025

Medicamentos antirretrovíricos para a terapêutica da infeção por VIH

Contract value
€410,509.84
Signed on
18 December 2025
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 12792487

PUBLISHED SUBJECT

41/493/2026 - Medicamentos antirretrovíricos para a terapêutica da infeção por VIH

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
PT150 - Algarve

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
GILEAD SCIENCES, LDA. · Tax ID 503604704
Awardee
JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412
Awardee
MYLAN, LDA. · Tax ID 502248793
Awardee
VIIVHIV HEALTHCARE, UNIPESSOAL LDA · Tax ID 509117961
Awardee
MERCK SHARP & DOHME LDA · Tax ID 500191360

Values and timeline

Contract price
€410,509.84
Procedure base price
€410,509.84
Total effective price
Not reported on Portal BASE
Publication date
22 January 2026
Award date
18 December 2025
Signing date
18 December 2025
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
900/2024 - Concurso público internacional para formação do acordo quadro de medicamentos antirretrovíricos para o tratamento da infeção por VIH na área da saúde
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
8857729

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts